Tag: CBT > Cannabis DEA

Cannabis Rescheduling

Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says

The Department of Justice argued that anti-rescheduling groups attempting to stay a Schedule III order have ‘pocketbook interests’ in prohibition.

July 8, 2026

Cannabis Rescheduling

DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing

The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.

June 26, 2026

Cannabis Rescheduling

Should DEA’s One-Sided Cannabis Rescheduling Hearing Be Reason for Concern?

The government may lack a sufficient administrative record to defend a Schedule III decision in judicial review without any pro-rescheduling participants.

June 24, 2026

Cannabis Rescheduling

DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties

Derek C. Julius will be the DEA’s chief administrative law judge to oversee the hearing of a proposed rule to reclassify cannabis as a Schedule III drug.

June 19, 2026

Cannabis Rescheduling

Feds Haven’t Provided ‘Clear Guidance, Feedback’ to Ohio on Cannabis Rescheduling

The state’s Division of Cannabis Control ‘doesn’t have a lot of great answers’ for its dual-licensed operators, the department’s legal counsel says.

June 18, 2026

Cannabis Rescheduling

3 States Challenge Trump DOJ’s Schedule III Cannabis Rule

Nebraska, Indiana and Louisiana filed a petition for review in federal court, arguing that immediately rescheduling medical cannabis violates administrative procedures.

May 27, 2026

Hemp-Derived Cannabinoids

White House’s ‘New Legal Authority’ for Hemp THC Products Leads CBT’s Top Stories in May

The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.

May 27, 2026

Cannabis Rescheduling

Cresco Labs Marks Historic Step Forward With Medical Cannabis Facility DEA Registrations

The registrations are for the company’s dispensary, cultivation and processing operations.

May 27, 2026

Cannabis Rescheduling

DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs

The application for non-dispensary businesses to handle Schedule III medical cannabis will be available in the coming weeks.

May 11, 2026

Cannabis Rescheduling

LEEF Brands Files Applications for DEA Registration, Positioning for Interstate and Global Export Opportunities

The California cannabis company expects interstate and global exports to provide an opportunity to sell into other markets at meaningfully higher prices.

May 8, 2026

Cannabis Rescheduling

Medical Cannabis Businesses ‘Need to Register’ With DEA to Be Schedule III Compliant

The DOJ’s rescheduling order does ‘not immediately’ bring state-licensed operators into compliance with federal law, congressional researchers say.

May 4, 2026

Cannabis Rescheduling

DEA Schedule III Registration Asks Cannabis Businesses to Admit to Drug Trafficking

State-licensed medical cannabis businesses have 60 days to apply for the federal registration to receive an expedited review; providing false info is punishable by jail.

April 30, 2026